Mediera Corporation (TPEX:5398)
19.60
-0.05 (-0.25%)
May 14, 2025, 10:51 AM CST
Mediera Revenue
Mediera had revenue of 25.85M TWD in the quarter ending March 31, 2025, a decrease of -33.46%. This brings the company's revenue in the last twelve months to 225.48M, up 24.39% year-over-year. In the year 2024, Mediera had annual revenue of 238.48M with 23.63% growth.
Revenue (ttm)
225.48M
Revenue Growth
+24.39%
P/S Ratio
4.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
972.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 238.48M | 45.59M | 23.63% |
Dec 31, 2023 | 192.90M | -64.65M | -25.10% |
Dec 31, 2022 | 257.55M | -94.01M | -26.74% |
Dec 31, 2021 | 351.56M | -16.33M | -4.44% |
Dec 31, 2020 | 367.88M | -65.09M | -15.03% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |